| How are missing data in covariates handled in observational time-to-event studies in oncology? A systematic review OU Carroll, TP Morris, RH Keogh BMC medical research methodology 20, 1-15, 2020 | 45 | 2020 |
| Comparative effectiveness of second line oral antidiabetic treatments among people with type 2 diabetes mellitus: emulation of a target trial using routinely collected health data P Bidulka, DG Lugo-Palacios, O Carroll, S O’Neill, AI Adler, A Basu, ... bmj 385, 2024 | 10 | 2024 |
| Development of risk prediction models to predict urine culture growth for adults with suspected urinary tract infection in the emergency department: protocol for an electronic … P Rockenschaub, MJ Gill, D McNulty, O Carroll, N Freemantle, ... Diagnostic and prognostic research 4, 1-9, 2020 | 9 | 2020 |
| Can the application of machine learning to electronic health records guide antibiotic prescribing decisions for suspected urinary tract infection in the Emergency Department? P Rockenschaub, MJ Gill, D McNulty, O Carroll, N Freemantle, ... PLOS Digital Health 2 (6), e0000261, 2023 | 4 | 2023 |
| Strategies for imputing missing covariate values in observational data O Carroll London School of Hygiene & Tropical Medicine, 2022 | 3 | 2022 |
| Improving transportability of randomized controlled trial inference using robust prediction methods MR Elliott, O Carroll, R Grieve, J Carpenter Statistical Methods in Medical Research 32 (12), 2365-2385, 2023 | 2 | 2023 |
| Going beyond randomised controlled trials to assess treatment effect heterogeneity across target populations DG Lugo‐Palacios, P Bidulka, S O’Neill, O Carroll, A Basu, A Adler, ... Health Economics, 2025 | | 2025 |
| A nationwide longitudinal investigation on the role of prenatal exposure to infectious diseases on the onset of chronic conditions in children and adolescents in Brazil ES Paixao, T Cerqueira-Silva, PTV Florentino, O Carroll, NS Clemente, ... Wellcome open research 9, 320, 2024 | | 2024 |
| 1042-P: Long-Term Complications after Add-on Treatment to Metformin—UK Real-World Progression in Diabetes (RAPIDS) Model AI ADLER, O CARROLL, P BIDULKA, A BASU, R GRIEVE Diabetes 73 (Supplement_1), 2024 | | 2024 |
| 1398-P: Emulating Target Trials Using Instrumental Variables to Inform Care—Add-on Therapy to Metformin AI ADLER, DG LUGO-PALACIOS, P BIDULKA, O CARROLL, A BASU, ... Diabetes 73 (Supplement_1), 2024 | | 2024 |
| Using automated text classification to explore uncertainty in NICE appraisals for drugs for rare diseases L Wiedmann, J Blumenau, O Carroll, J Cairns International journal of technology assessment in health care 40 (1), e5, 2024 | | 2024 |
| Comparative effectiveness of alternative second-line oral antidiabetic treatments on metabolic, kidney, and cardiovascular outcomes amongst people with type 2 diabetes mellitus … D Lugo-Palacios, O Carroll, S O’Neill, A Adler, J Bartlett, D Nitsch, ... | | 2023 |
| Development of risk prediction models to predict urine culture growth for patients with 1 suspected urinary tract infection in the emergency department: protocol for an 2 … P Rockenschaub, MJ Gill, D McNulty, O Carroll, N Freemantle, ... | | 2020 |
| PROTOCOL Open Access P Rockenschaub, MJ Gill, D McNulty, O Carroll, N Freemantle, ... | | 2020 |
| Treatment patterns of systemic antifungal dispensation in hospitals in England: An analysis of the health treatment insights database OU Carroll, RL Tham, BD Bray, H Dattani, D Layton PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 28, 504-505, 2019 | | 2019 |
| Temporal trends in the dispensation of systemic antifungal therapy in hospitals in England: An analysis of the health treatment insights database RL Tham, OU Carroll, BD Bray, H Dattani, D Layton, J Kim PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 28, 509-510, 2019 | | 2019 |
| WS10-2 Investigating differences in outcomes in people with cystic fibrosis with a nonsense mutation, compared to the total cystic fibrosis patient population and patients … S Carr, O Carroll, S Cunningham, N Simmonds, R Cosgriff, S Newsome, ... Journal of Cystic Fibrosis 18, S18, 2019 | | 2019 |
| Methods for handling unobserved covariates in a Bayesian update of a cost-effectiveness model B Thorpe, O Carroll, L Sharples Medical Decision Making 38 (2), 150-162, 2018 | | 2018 |
